Palvella Therapeutics (PVLA) Earnings Date, Estimates & Call Transcripts $21.67 -0.03 (-0.14%) As of 10:28 AM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Palvella Therapeutics Earnings Summary Palvella Therapeutics issued Q1 2025 earnings on May 15, 2025, reporting an EPS of -$0.74, which beat the consensus estimate of -$3.40 by $2.66. With a trailing EPS of -$12.10, Palvella Therapeutics' earnings are expected to grow next year, from ($3.69) to ($2.77) per share. Latest Q1 Earnings DateMay. 15EstimatedConsensus EPS (May. 15) -$3.40 Actual EPS (May. 15) -$0.74 Beat By $2.66 Q1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Slide DeckSlide DeckFull Screen Slide DeckPowered by Get Palvella Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Palvella Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Palvella Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$3.56-$3.56-$3.56Q2 20251-$3.79-$3.79-$3.79Q3 20251-$4.05-$4.05-$4.05Q4 20251-$4.33-$4.33-$4.33 Palvella Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails5/15/2025Q1 2025-$3.40-$0.74+$2.66-$0.74-- Palvella Therapeutics Earnings - Frequently Asked Questions When is Palvella Therapeutics's earnings date? Palvella Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 15th, 2025 based off last year's report dates. Learn more on PVLA's earnings history. Did Palvella Therapeutics beat their earnings estimates last quarter? In the previous quarter, Palvella Therapeutics (NASDAQ:PVLA) reported ($0.74) earnings per share (EPS) to beat the analysts' consensus estimate of ($3.40) by $2.66. Learn more on analysts' earnings estimate vs. PVLA's actual earnings. How much revenue does Palvella Therapeutics generate each year? Palvella Therapeutics (NASDAQ:PVLA) has a recorded annual revenue of $42.81 million. How much profit does Palvella Therapeutics generate each year? Palvella Therapeutics (NASDAQ:PVLA) has a recorded net income of -$24.54 million. PVLA has generated -$12.10 earnings per share over the last four quarters. What is Palvella Therapeutics's EPS forecast for next year? Palvella Therapeutics's earnings are expected to grow from ($3.69) per share to ($2.77) per share in the next year. More Earnings Resources from MarketBeat Related Companies PAHC Earnings Date COLL Earnings Date RCUS Earnings Date SYRE Earnings Date PHVS Earnings Date AVDL Earnings Date NTLA Earnings Date CMRX Earnings Date CDMO Earnings Date SNDX Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles D-Wave Pushes Back on Short Seller Case With Strong EarningsAppLovin Surges on Earnings: What's Next for This Tech Standout?Can Shopify Stock Make a Comeback After an Earnings Sell-Off?Rocket Lab: Earnings Miss But Neutron Momentum HoldsWhy Nearly 20 Analysts Raised Meta Price Targets Post-EarningsOXY Stock Rebound Begins Following Solid Earnings BeatMonolithic Power Systems: Will Strong Earnings Spark a Recovery? This page (NASDAQ:PVLA) was last updated on 5/15/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredSilver Demand Is Soaring-Supply Can't Keep UpSilver demand hit 1.16 billion ounces in 2024-while supply fell short again for the fourth year in a row. I...i2i Marketing Group, LLC | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredThe Man I Turn to In Times Like ThisA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Palvella Therapeutics Please log in to your account or sign up in order to add this asset to your watchlist. Share Palvella Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
